- Home
- Publications
- Publication Search
- Publication Details
Title
Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
Authors
Keywords
-
Journal
Blood Advances
Volume 4, Issue 12, Pages 2762-2767
Publisher
American Society of Hematology
Online
2020-06-22
DOI
10.1182/bloodadvances.2019001416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
- (2018) Patrick Casara et al. Oncotarget
- Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
- (2018) Donia M. Moujalled et al. LEUKEMIA
- Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
- (2018) Courtney D. DiNardo et al. BLOOD
- Dysregulation of BCL-2 family proteins by leukemia fusion genes
- (2017) Lauren M. Brown et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
- (2016) S. L. Khaw et al. BLOOD
- Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
- (2016) Nitin Jain et al. BLOOD
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia
- (2016) Jessica T. Leonard et al. Science Translational Medicine
- New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia
- (2015) Elias Jabbour et al. CANCER
- MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
- (2015) Juliana M. Benito et al. Cell Reports
- Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia
- (2013) B. Koss et al. BLOOD
- Structure-guided design of a selective BCL-XL inhibitor
- (2013) Guillaume Lessene et al. Nature Chemical Biology
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Case Series
- (2010) Piper M. Treuting et al. TOXICOLOGIC PATHOLOGY
- Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML
- (2009) J. A. Powell et al. BLOOD
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic Exercise
- (2009) E. Radaelli et al. VETERINARY PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started